Resistance of polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2D(k)-restricted epitope in the middle T protein

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1724-1734

  Lukacher, Aron E ^a   Wilson, Christopher S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; H2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; VIRUS MIDDLE T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR RECOGNITION; MOUSE; MOUSE STRAIN; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; TUMOR RESISTANCE; VIRUS CARCINOGENESIS;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE; CELL SEPARATION; CLONE CELLS; DISEASE SUSCEPTIBILITY; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; IMMUNITY, NATURAL; IMMUNODOMINANT EPITOPES; LYMPHOCYTE COUNT; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED ICR; PAPILLOMAVIRUS INFECTIONS; PEPTIDE FRAGMENTS; POLYOMAVIRUS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS;

EID: 0032519951     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumors. Adv. Immunol. 49:281.
2. Craig, F. E., M. L. Gulley, and P. M. Banks. 1993. Post-transplantation lymphoproliferative disorders. Am. J. Clin. Pathol. 99:265.
3. Rooney, C. M., C. A. Smith, C. Y. C. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9.
4. Kjaer, S. K., A. J. C. Van Den Brule, J. E. Bock, P. A. Poll, G. Engholm, M. E. Sherman, J. M. M. Walboomer, and C. J. L. M. Meijer. 1996. Human papillomavirus: the most significant risk determinant of cervical intraepithelial neoplasia. Int. J. Cancer 65:601.
5. Petry, K. U., D. Scheffel, U. Bode, T. Gabrysiak, H. Kochel, E. Kupsch, M. Glaubitz, S. Niesert, H. Kuhnle, and I. Schedel. 1994. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int. J. Cancer 57:836.
6. Keating, P. J., F. V. Cromme, M. Duggan-Keen, P. J. F. Snijders, J. M. M. Walboomers, R. D. Hunter, P. A. Dyer, and P. L. Stern. 1995. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer 72:405.
7. Ellis, J. R. M., P. J. Keating, B. J., E. F. Hounsell, D. V. Renouf, M. Rowe, D. Hopkins, M. F. Dugan-Keen, Y. L. S., and P. L. Stern. 1995. The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1:565.
8. Dawe, C. J., R. Freund, G. Mandel, K. Ballmer-Hofer, D. A. Talmage, and T. L. Benjamin. 1987. Variations in polyoma virus genotype in relation to tumor induction in mice: characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol. 127:243.
9. Raptis, L., H. Lamfrom, and T. L. Benjamin. 1985. Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts. Mol. Cell. Biol. 5:2476.
10. Garcea, R. L., D. A. Talmage, A. Harmatz, R. Freund, and T. L. Benjamin. 1989. Separation of host range from transformation functions of the hr-t gene of polyomavirus. Virology 168:312.
11. Freund, R., A. Sotnikov, R. T. Bronson, and T. L. Benjamin. 1992. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 191:716.
12. Law, L. W., R. C. Ting, and E. Leckband. 1967. Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc. Natl. Acad. Sci. USA 57:1068.
13. Allison, A. C., J. N. Monga, and V. Hammond. 1974. Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature 252:746.
14. b molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity. J. Virol. 70:3093.
15. Gross, L. G. 1983. Oncogenic Viruses. Pergamon Press, Oxford, p. 737.
16. Freund, R., T. Dubensky, R. Bronson, A. Sotkinov, J. Carroll, and T. Benjamin. 1992. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology 191:724.
17. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459.
18. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leeman, J. C. Laning, M. E. Dorf, and T. L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181:1683.
19. Green, M. I., L. L. Perry, E. Kinney-Thomas, and T. L. Benjamin. 1982. Specific thymus-derived (T) cell recognition of papova virus-transformed cells. J. Immunol. 128:732.
20. Ward, P. L., H. Koeppen, T. Hurteau, and H. Schreiber. 1989. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 170:217.
21. O'Connell, K. A., and L. R. Gooding. 1984. Cloned cytotoxic T lymphocytes recognize cells expressing discrete fragments of the SV40 tumor antigen. J. Immunol. 132:953.
22. Braciale, T. J., M. E. Andrew, and V. L. Braciale. 1981. Heterogeneity and specificity of cloned lines of influenza-virus-specific cytotoxic T lymphocytes. J. Exp. Med. 153:910.
23. Quintans, J., and I. Lefkovits. 1973. Precursor cells specific to sheep red cells in nude mice. Estimation of frequency in the microculture system. Eur. J. Immunol. 3:392.
24. Shadan, F. F., L. M. Cowsert, and L. P. Villarreal. 1994. n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses. J. Virol. 68:4785.
25. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491.
26. Casanova, J.-L., P. Romero, C. Widmann, P. Kourilsky, and J. L. Maryanski. 1991. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium burghei nonapeptide: implications for T cell allelic exclusion and antigenic-specific repertoire. J. Exp. Med. 174:1371.
27. Hood, L., M. Steinmetz, and B. Malissen. 1983. Genes of the major histocompatibility complex of the mouse. Annu. Rev. Immunol. 1:529.
28. de Bergeyck, V., E. De Plaen, P. Chomez, T. Boon, and A. Van Pel. 1994. An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur. J. Immunol. 24:2203.
29. k loci: evolutionary relationships to H-2 genes from four other mouse strains. J. Immunol. 139:3878.
30. Young, A. C. M., S. G. Nathenson, and J. C. Sacchettini. 1995. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J. 9:26.
31. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035.
32. Falk, K., O. Rotzchke, K. Deres, J. Metzger, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
33. b at 2.4A resolution: implications for antigen determinant selection. Cell 76:39.
34. d exploits a four residue peptide binding motif. J. Exp. Med. 178:1877.
35. k-restricted cytotoxic T cell epitope in the NS1 protein of influenza virus using an MHC allele-specific motif. Virology 193:289.
36. van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Marali-Krishna, L. L. Lau, S. Southjwood, J. Sidney, R. W. Chesnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543.
37. Sijts, A. J. A. M., A. Neisig, J. Neefjes, and E. G. Pamer. 1996. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J. Immunol. 156:685.
38. Selin, L. K., and R. M. Welsh. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J. Immunol. 158:5366.
39. Behlke, M. A., H. S. Chou, K. Huppi, and D. Y. Loh. 1986. Murine T-cell receptor mutants with deletions of β-chain variable region genes. Proc. Natl. Acad. Sci. USA 83:767.
40. Nanda, N. K., R. Apple, and E. E. Sercarz. 1991. Limitations in plasticity of the T cell receptor repertoire. Proc. Natl. Acad. Sci. USA 88:9503.
41. Nanda, N. K., and E. Sercarz. 1996. A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant. J. Exp. Med. 184:1037.
42. + CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J. Immunol. 157:505.
43. + memory T cells specific for a subdominant epitope following Sendai virus infection. J. Immunol. 158:4301.
44. Wirth, J. J., and M. M. Fluck. 1991. Immunological elimination of infected cells as the candidate mechanism for tumor protection in polyomavirus-infected mice. J. Virol. 65:6985.
45. Ljunggren, G., H.-G. Ljunggren, and T. Dalianis. 1994. T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198:714.
46. Talmage, D. A., R. Freund, T. Dubensky, M. Salcedo, P. Gariglio, L. M. Rangel, C. J. Dawe, and T. L. Benjamin. 1992. Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology 187:734.
47. Tanaka, Y., M. J. Tevethia, D. Kalderon, A. E. Smith, and S. S. Tevethia. 1988. Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen. Virology 162:427.
48. Kast, W. M., R. Offringa, P. J. Peters, A. C. Voordouw, R. H. Meloen, A. J. van der Erb, and C. J. M. Melief. 1989. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603.
49. Murray, R. J., M. G. Kurilla, J. M. Brooks, W. A. Thomas, M. Rowe, E. Kieff, and A. B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med 176:157.
50. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M.-F. Del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
51. Bachmann, M. F., D. E. Speiser, and P. S. Ohashi. 1997. Functional maturation of an antiviral cytotoxic T-cell response. J. Virol. 71:5764.
52. Toes, E. E., M. C. Feltkamp, M. E. Ressing, M. P. Vierboom, R. J. Blom, R. M. Brandt, M. Hartman, R. Offringa, C. J. Melief, and W. M. Kast. 1995. Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape. Biochem. Soc. Trans. 23:692.
53. Wirth, J. L., A. Amalfitano, R. Gross, M. B. A. Oldstone, and M. M. Fluck. 1992. Organ- and age-specific replication of polyomavirus in mice. J. Virol. 66:3278.
54. Wirth, J. J., L. G. Martin, and M. M. Ruck. 1997. Oncogenesis of mammary glands, skin, and bones by polyomavirus correlates with viral persistence and prolonged genome replication potential. J. Virol. 71:1072.
55. Ahmed, R., A. Salmi, L. D. Butler, J. Chiller, and M. B. A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role of suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 60:521.
56. Moskophidis, D., F. Lechner, H. P. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
57. Moss, D. J., S. R. Burrows, G. D. Baxter, and M. F. Lavin. 1991. T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism. J. Exp. Med. 173:681.
58. Alexander-Miller, M. A., G. R. Leggatt, A. Sarin, and J. A. Berzofsky. 1996. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 184:485.
59. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1579.
60. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
61. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβ T cell receptor structure at 2.5A and its orientation in the TCR-MHC complex. Science 274:209.
62. Cole, G. A., T. L. Hogg, and D. L. Woodland. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767.
63. Horwitz, M. S., Y. Yanagi, and M. B. A. Oldstone. 1994. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity. J. Virol. 68:352.
64. b class I molecule. Cell. Immunol. 160:33.
65. a-encoded antigens. Nature 332:40.
66. Radovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, and A. Lanzavecchia. 1993. Expression of two T cell receptor α chains: dual receptor T cells. Science 262:.
67. Hardardottir, F., J. L. Baron, and C. A. Janeway. 1995. T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA 92:354.
68. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
69. Nanda, N. K., K. K. Arzoo, H. M. Geysen, A. Sette, and E. E. Sercarz. 1995. Recognition of multiple peptide cores by a single T cell receptor. J. Exp. Med. 182:531.
70. Tallquist, M. D., T. J. Yun, and L. R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184:1017.
71. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
72. k-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J. Virol. 65:5401.